Endovascular Treatment of Peripheral Artery Disease (PAD)

NCT03414515 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-09-05

No results posted yet for this study

Summary

The purpose of this observational study is to evaluate the performance and safety of endovascular treatment with stenting (Optimed Sinus Superflex 635 or Qualimed Pontos-pp) or balloon angioplasty (Cardionovum Legflow or Optimed Nylotrack .035 + .018) according to current practice. The goal of the study will be achieved by assessing binary restenosis with duplex ultrasound, peri- and postoperative complications, technical success, target lesion revascularization, amputation and clinical outcome.

Conditions

  • Peripheral Arterial Disease
  • Iliac Artery Disease
  • Femoropopliteal Occlusive Disease
  • Below-the-knee Obstruction

Interventions

DEVICE

Endovascular intervention

Endovascular treatment with stent or balloon according to current practice

Sponsors & Collaborators

  • Duomed

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-02
Primary Completion
2021-12-01
Completion
2021-12-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03414515 on ClinicalTrials.gov